MapLight Therapeutics, Inc. · 2 months ago
Director, Clinical Pharmacology & Pharmacometrics
Burlington, MA
Full-time
Onsite
Director/Executive
$208K/yr - $260K/yr
6+ years expMapLight Therapeutics is a clinical stage biotech company focused on drug discovery for central nervous system disorders. The Director of Clinical Pharmacology & Pharmacometrics will lead clinical pharmacology and pharmacometrics efforts, applying expertise in pharmacokinetics and pharmacodynamics to guide dose selection and optimize therapies throughout clinical development.
BiopharmaBiotechnologyLife ScienceMedical
Responsibilities
As a core member of clinical program team, and as the clinical pharmacology and pharmacometrics lead provide strategic input into the progression of drug candidates from pre-IND through NDA submission
Design and provide input into Phase 1–3 clinical study protocols, reports, and related clinical documentation
Perform, interpret, and communicate PK and PD analyses to support dose selection and clinical decision-making
Provide scientific rationale for dose selection and regimen optimization throughout clinical development
Author and contribute to regulatory submissions and represent the company in interactions with global health authorities
Qualification
Required
Ph.D. in Pharmaceutical Sciences or a related discipline
Formal training in Pharmacokinetics, Pharmacodynamics, and Drug Metabolism
Minimum of 6 years of experience in clinical drug development, preferably with small molecules
Demonstrated expertise in PK and PK/PD modeling, including recent applications using NONMEM
Strong scientific communication and presentation skills
Proven publication record in the field of clinical pharmacology and pharmacometrics
Benefits
Annual bonus opportunity
Medical
Dental
Vision
Life and AD&D
Short term and long term disability
401(K) plan with match
Stock options
Flexible non-accrual paid time off
Parental leave
Company
MapLight Therapeutics, Inc.
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
51-200 employees
H1B Sponsorship
MapLight Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (1)
Funding
Current Stage
Public CompanyTotal Funding
$640.6MKey Investors
Michael J. Fox Foundation
2025-10-27IPO
2025-07-28Series D· $372.5M
2023-10-30Series C· $225M
Leadership Team
Vishwas Setia
Chief Financial Officer
Recent News
2026-01-11
2026-01-06
Company data provided by crunchbase